Journal of Hematology & Oncology operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
Official journal of
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
- Editorial Board
- Sign up for article alerts and news from this journal
Annual Journal Metrics
37 days to first decision for reviewed manuscripts only
41 days to first decision for all manuscripts
79 days from submission to acceptance
15 days from acceptance to publication
7.333 - 2-year Impact Factor
6.457 - 5-year Impact Factor
1.316 - Source Normalized Impact per Paper (SNIP)
2.292 - SCImago Journal Rank (SJR)
376 Altmetric mentions